If social media is any guide, there are a large number of investors who are blinded by greed to such an extent that the sound advice to be careful falls on deaf ears. After giving considerable thought to this issue, I am writing this column to show investors how to sensibly speculate on Ebola-related stocks with an actionable example.
Let us start with the annotated chart of OraSure Technologies OSUR.
Please click here to see the annotated chart of OSUR.
One of the difficulties is that there is no rapid-detection test for Ebola. OraSure is known for its rapid HIV tests, including the first in-home oral HIV test. HIV is caused by a virus. Ebola is a virus. OraSure also has a subsidiary that is a leader in oral-fluid-sample collection.
In terms of speculation, given OraSure’s capabilities in virus detection, it stands to reason that OraSure would be exploring or working on an Ebola test. Please note that I have no confirmed information In this regard and the foregoing speculation may turn out to be entirely wrong.
The attraction of OraSure is that unlike other companies with even a remote connection to Ebola, OraSure stock has not run up. There is a strong support nearby that allows, from a trading perspective, close stops to control risk. On the positive side, if the company is able to show progress on an Ebola test, based on the price action in the other Ebola stocks, this stock can triple or quadruple quickly…Read more on MarketWatch
You are receiving less than 2% of the content from our paid services …TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES.
Please click here to take advantage of a FREE 30 day trial.
Check out our enviable performance in both bull and bear markets.
